CoChat
Sign Up
Cited by 19

The DOI matches its Crossref record.

The RND1 Small GTPase: Main Functions and Emerging Role in Oncogenesis

Mouly, Laetitia, Gilhodes, Julia, Lemarié, Anthony, Cohen-Jonathan Moyal, Elizabeth, Toulas, Christine, Favre, Gilles, Sordet, Olivier, Monferran, Sylvie·2019·International Journal of Molecular Sciences
DOI 10.3390/ijms20153612PMC PMC6696182
Open this paper in CoChat — free account

Abstract

The Rho GTPase family can be classified into classic and atypical members. Classic members cycle between an inactive Guanosine DiPhosphate -bound state and an active Guanosine TriPhosphate-bound state. Atypical Rho GTPases, such as RND1, are predominantly in an active GTP-bound conformation. The role of classic members in oncogenesis has been the subject of numerous studies, while that of atypical members has been less explored. Besides the roles of RND1 in healthy tissues, recent data suggest that RND1 is involved in oncogenesis and response to cancer therapeutics. Here, we present the current knowledge on RND1 expression, subcellular localization, and functions in healthy tissues. Then, we review data showing that RND1 expression is dysregulated in tumors, the molecular mechanisms involved in this deregulation, and the role of RND1 in oncogenesis. For several aggressive tumors, RND1 presents the features of a tumor suppressor gene. In these tumors, low expression of RND1 is associated with a bad prognosis for the patients. Finally, we highlight that RND1 expression is induced by anticancer agents and modulates their response. Of note, RND1 mRNA levels in tumors could be used as a predictive marker of both patient prognosis and response to anticancer agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms20153612

Cites

Statistics

Figures

Figure 1 Rho GTPase family. The phylogenetic tree of the Rho GTPase family was obtained from the alignment of the amino-acid sequences of the 20 Rho GTPases using the Clustal Omega program. The tree was generated using the iTOL software. Rho members are structured into eight subfamilies, including the Rho subfamily (RHOA, RHOB, and RHOC), the RAC subfamily (RAC1, RAC2, RAC3, and RHOG), the CDC42 subfamily (CDC42, RHOQ and RHOJ), the RND subfamily (RND1, RND2 and RND3), the RHOU/V family (RHOU and RHOV), the RHOD/F subfamily (RHOD and RHOF), the RHOBTB subfamily (RHOBTB1 and RHOBTB2) and RHOH. Classic Rho GTPases comprise the RHO, RAC, CDC42, and RHOD/F subfamilies. Atypical Rho GTPases include the RND, RHOU/V, RHOBTB, and RHOH subfamilies. Rho GTPases, which have a knockout (KO) mouse model, are annotated with a triangle. Percentage of amino-acid-sequences identity between RND1 and other Rho GTPases members were determined with the Clustal Omega tool.
Figure 1 Rho GTPase family. The phylogenetic tree of the Rho GTPase family was obtained from the alignment of the amino-acid sequences of the 20 Rho GTPases using the Clustal Omega program. The tree was generated using the iTOL software. Rho members are structured into eight subfamilies, including the Rho subfamily (RHOA, RHOB, and RHOC), the RAC subfamily (RAC1, RAC2, RAC3, and RHOG), the CDC42 subfamily (CDC42, RHOQ and RHOJ), the RND subfamily (RND1, RND2 and RND3), the RHOU/V family (RHOU and RHOV), the RHOD/F subfamily (RHOD and RHOF), the RHOBTB subfamily (RHOBTB1 and RHOBTB2) and RHOH. Classic Rho GTPases comprise the RHO, RAC, CDC42, and RHOD/F subfamilies. Atypical Rho GTPases include the RND, RHOU/V, RHOBTB, and RHOH subfamilies. Rho GTPases, which have a knockout (KO) mouse model, are annotated with a triangle. Percentage of amino-acid-sequences identity between RND1 and other Rho GTPases members were determined with the Clustal Omega tool.CC BY · PubMed Central
Figure 2 Structure of RND1 gene and mutational pattern in human tumors. The orange box is the lipid raft motif; the yellow boxes are the guanosine nucleotide binding sites; the pink box is Rho insert domain; the blue boxes are the switch domains. SI: Switch I; SII: Switch II. Mutation types and corresponding color codes are as follows: Black represents the missense mutations and green represents the nonsense mutations. The stars indicate the mutations for which the impact on the RND1 function has been studied [10].
Figure 2 Structure of RND1 gene and mutational pattern in human tumors. The orange box is the lipid raft motif; the yellow boxes are the guanosine nucleotide binding sites; the pink box is Rho insert domain; the blue boxes are the switch domains. SI: Switch I; SII: Switch II. Mutation types and corresponding color codes are as follows: Black represents the missense mutations and green represents the nonsense mutations. The stars indicate the mutations for which the impact on the RND1 function has been studied [10].CC BY · PubMed Central
Figure 3 Regulation of RND1 protein in healthy and cancer cells. 1: RND1 transcription is regulated by diverse mechanisms. In healthy cells, the transcription factor NFATc1 increases RND1 transcription (marked as “+” in the figure). In cancer cells, the transcription factor Oct4, the lncRNA AGAP2-AS1 and epigenetic mechanisms, including DNA methylation and histone acetylation, act as repressors of RND1 transcription (marked as “−” in the figure) whereas PARP-1 stimulates RND1 transcription (marked as “+” in the figure). 2: RND1 expression is inhibited by the miRNAs miR-199a-5p and miR-603. The 3′UTR of RND1 mRNA has one or more specific binding sites for miR-199a-5p whereas the binding sites for miR-603 have not yet been identified. 3: RND1 protein is stabilized when it associates with its effectors p190RhoGAP and Syx. When RND1 is phosphorylated, it binds to the 14-3-3 protein, which induces the translocation of RND1 from the plasma membrane to the cytoplasm.
Figure 3 Regulation of RND1 protein in healthy and cancer cells. 1: RND1 transcription is regulated by diverse mechanisms. In healthy cells, the transcription factor NFATc1 increases RND1 transcription (marked as “+” in the figure). In cancer cells, the transcription factor Oct4, the lncRNA AGAP2-AS1 and epigenetic mechanisms, including DNA methylation and histone acetylation, act as repressors of RND1 transcription (marked as “−” in the figure) whereas PARP-1 stimulates RND1 transcription (marked as “+” in the figure). 2: RND1 expression is inhibited by the miRNAs miR-199a-5p and miR-603. The 3′UTR of RND1 mRNA has one or more specific binding sites for miR-199a-5p whereas the binding sites for miR-603 have not yet been identified. 3: RND1 protein is stabilized when it associates with its effectors p190RhoGAP and Syx. When RND1 is phosphorylated, it binds to the 14-3-3 protein, which induces the translocation of RND1 from the plasma membrane to the cytoplasm.CC BY · PubMed Central
Figure 4 RND1 is involved in the formation of nerve connections. (A) Plexin dependent mechanisms. 1: The interaction of RND1 with plexin A1 stimulates its R-Ras GTPase activity, leading to the growth cone collapse. This effect occurs even in the absence of a semaphorin signal. This interaction can be inhibited by RhoD, which binds the plexin to the same binding site as RND1. 2: After stimulation by semaphorin 4D (Sema4D), the interaction of RND1 with plexin B1 stimulates its R-Ras GTPase activity and its binding with PDZ-RhoGEF, resulting in the inhibition of R-Ras and the activation of RhoA, respectively. These mechanisms both contribute to growth cone collapse and neurite retraction. (B) Plexin independent mechanisms. The interaction of RND1 with STI1 inhibits growth cone collapse inhibition induced by the RND1-Plexin A1 association and increases neurite extension. Binding of RND1 with SCG10 induces microtubule depolymerization and axon extension.
Figure 4 RND1 is involved in the formation of nerve connections. (A) Plexin dependent mechanisms. 1: The interaction of RND1 with plexin A1 stimulates its R-Ras GTPase activity, leading to the growth cone collapse. This effect occurs even in the absence of a semaphorin signal. This interaction can be inhibited by RhoD, which binds the plexin to the same binding site as RND1. 2: After stimulation by semaphorin 4D (Sema4D), the interaction of RND1 with plexin B1 stimulates its R-Ras GTPase activity and its binding with PDZ-RhoGEF, resulting in the inhibition of R-Ras and the activation of RhoA, respectively. These mechanisms both contribute to growth cone collapse and neurite retraction. (B) Plexin independent mechanisms. The interaction of RND1 with STI1 inhibits growth cone collapse inhibition induced by the RND1-Plexin A1 association and increases neurite extension. Binding of RND1 with SCG10 induces microtubule depolymerization and axon extension.CC BY · PubMed Central
Figure 5 RND1 is involved in adhesion and migration during embryogenesis. In Xenopus embryos, RND1 can bind both the FLRT3 transmembrane protein and the netrin receptor, Unc5B. The association between RND1 and FLRT3 decreases the level of C-cadherin present on the cell surface through internalization of C-cadherin into endocytic vesicles in the cytoplasm, resulting in cell adhesion inhibition. The effect of the interaction with Unc5B on the internalization of C-cadherin has not yet been studied. RND1 also allows endo-mesodermal cells to migrate during embryogenesis, which leads to gastrulation.
Figure 5 RND1 is involved in adhesion and migration during embryogenesis. In Xenopus embryos, RND1 can bind both the FLRT3 transmembrane protein and the netrin receptor, Unc5B. The association between RND1 and FLRT3 decreases the level of C-cadherin present on the cell surface through internalization of C-cadherin into endocytic vesicles in the cytoplasm, resulting in cell adhesion inhibition. The effect of the interaction with Unc5B on the internalization of C-cadherin has not yet been studied. RND1 also allows endo-mesodermal cells to migrate during embryogenesis, which leads to gastrulation.CC BY · PubMed Central
Figure 6 RND1 limits angiogenesis. Vascular endothelial growth factor (VEGF) activates calcineurin-NFATc1 signaling axis. Nuclear localized NFATc1 binds to the RND1 promoter and stimulates its transcription. The increase of RND1 decreases RHOA activation resulting in the inhibition of angiogenesis.
Figure 6 RND1 limits angiogenesis. Vascular endothelial growth factor (VEGF) activates calcineurin-NFATc1 signaling axis. Nuclear localized NFATc1 binds to the RND1 promoter and stimulates its transcription. The increase of RND1 decreases RHOA activation resulting in the inhibition of angiogenesis.CC BY · PubMed Central
Figure 7 Correlation between RND1 expression and sensitivity to anticancer agents in hematological and lymphoid tumor cells. Using the CCLE database, correlations between quantitative data were determined as in Table 2. Two-sided p-values of less than 0.05 were considered statistically significant. All statistical analyses were performed using STATA 12.0 software.
Figure 7 Correlation between RND1 expression and sensitivity to anticancer agents in hematological and lymphoid tumor cells. Using the CCLE database, correlations between quantitative data were determined as in Table 2. Two-sided p-values of less than 0.05 were considered statistically significant. All statistical analyses were performed using STATA 12.0 software.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 62

  1. Heasman, 2008, Mammalian Rho GTPases: New insights into their functions from in vivo studies, Nat. Rev. Mol. Cell Biol., 9, 690, 10.1038/nrm2476 · DOI · Paper page
  2. Bustelo, 2018, RHO GTPases in cancer: Known facts, open questions, and therapeutic challenges, Biochem. Soc. Trans., 46, 741, 10.1042/BST20170531 · DOI
  3. Nobes, 1998, A New Member of the Rho Family, Rnd1, Promotes Disassembly of Actin Filament Structures and Loss of Cell Adhesion, J. Cell Boil., 141, 187, 10.1083/jcb.141.1.187 · DOI
  4. Shutes, 2004, Atypical Mechanism of Regulation of the Wrch-1 Rho Family Small GTPase, Curr. Boil., 14, 2052, 10.1016/j.cub.2004.11.011 · DOI
  5. Oinuma, 2012, Rnd1 and Rnd3 targeting to lipid raft is required for p190 RhoGAP activation, Mol. Biol. Cell, 23, 1593, 10.1091/mbc.e11-11-0900 · DOI
  6. Riou, 2010, Rnd proteins: Multifunctional regulators of the cytoskeleton and cell cycle progression, BioEssays, 32, 986, 10.1002/bies.201000060 · DOI
  7. Jaffe, 2005, RHO GTPASES: Biochemistry and Biology, Annu. Rev. Cell Dev. Boil., 21, 247, 10.1146/annurev.cellbio.21.020604.150721 · DOI · Paper page
  8. Ridley, 2015, Rho GTPase signalling in cell migration, Curr. Opin. Cell Biol., 36, 103, 10.1016/j.ceb.2015.08.005 · DOI
  9. Zandvakili, 2017, Rho GTPases: Anti- or pro-neoplastic targets?, Oncogene, 36, 3213, 10.1038/onc.2016.473 · DOI
  10. Okada, 2015, The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling, Nat. Cell Biol., 17, 81, 10.1038/ncb3082 · DOI
  11. Clarke, K., Daubon, T., Turan, N., Soulet, F., Mohd Zahari, M., Ryan, K.R., Durant, S., He, S., Herbert, J., and Ankers, J. (2015). Inference of Low and High-Grade Glioma Gene Regulatory Networks Delineates the Role of Rnd3 in Establishing Multiple Hallmarks of Cancer. PLoS Genet., 11. · DOI
  12. Grise, 2012, Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion, Hepatology, 55, 1766, 10.1002/hep.25568 · DOI
  13. Paysan, 2016, Rnd3 in Cancer: A Review of the Evidence for Tumor Promoter or Suppressor, Mol. Cancer Res., 14, 1033, 10.1158/1541-7786.MCR-16-0164 · DOI
  14. Blitz, 1999, Involvement of the small GTPases XRhoA and XRnd1 in cell adhesion and head formation in early Xenopus development, Development, 126, 5339, 10.1242/dev.126.23.5339 · DOI
  15. Ishikawa, 2003, A Role of Rnd1 GTPase in Dendritic Spine Formation in Hippocampal Neurons, J. Neurosci., 23, 11065, 10.1523/JNEUROSCI.23-35-11065.2003 · DOI
  16. Kim, 2005, Differences in the gestational pattern of mRNA expression of the Rnd family in rat and human myometria, Comp. Biochem. Physiol. Part A Mol. Integr. Physiol., 142, 410, 10.1016/j.cbpa.2005.08.028 · DOI
  17. Kim, 2003, Up-regulation of Rnd1 during pregnancy serves as a negative-feedback control for Ca2+ sensitization of contractile elements in rat myometrium, Biochem. Biophys. Res. Commun., 311, 972, 10.1016/j.bbrc.2003.10.100 · DOI
  18. Katoh, 2002, Socius Is a Novel Rnd GTPase-Interacting Protein Involved in Disassembly of Actin Stress Fibers, Mol. Cell. Biol., 22, 2952, 10.1128/MCB.22.9.2952-2964.2002 · DOI
  19. Roberts, 2008, Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification, J. Biol. Chem., 283, 25150, 10.1074/jbc.M800882200 · DOI · Paper page
  20. Riou, 2013, 14-3-3 Proteins Interact with a Hybrid Prenyl-Phosphorylation Motif to Inhibit G Proteins, Cell, 153, 1164, 10.1016/j.cell.2013.05.003 · DOI
  21. Song, 2014, Inhibition of osteoclast bone resorption activity through osteoprotegerin-induced damage of the sealing zone, Int. J. Mol. Med., 34, 856, 10.3892/ijmm.2014.1846 · DOI
  22. Suehiro, 2014, Genome-wide Approaches Reveal Functional Vascular Endothelial Growth Factor (VEGF)-inducible Nuclear Factor of Activated T Cells (NFAT) c1 Binding to Angiogenesis-related Genes in the Endothelium, J. Biol. Chem., 289, 29044, 10.1074/jbc.M114.555235 · DOI
  23. Loirand, 1999, The Rho-related protein Rnd1 inhibits Ca2+ sensitization of rat smooth muscle, J. Physiol., 516, 825, 10.1111/j.1469-7793.1999.0825u.x · DOI
  24. Monastyrskaya, 2013, miR-199a-5p Regulates Urothelial Permeability and May Play a Role in Bladder Pain Syndrome, Am. J. Pathol., 182, 431, 10.1016/j.ajpath.2012.10.020 · DOI · Paper page
  25. Zhang, 2016, Primate-specific miR-603 is implicated in the risk and pathogenesis of Alzheimer’s disease, Aging (Albany N. Y.), 8, 272
  26. Hodge, 2016, Regulating Rho GTPases and their regulators, Nat. Rev. Mol. Cell Biol., 17, 496, 10.1038/nrm.2016.67 · DOI · Paper page
  27. Goh, 2012, The GTPase-deficient Rnd Proteins Are Stabilized by Their Effectors, J. Biol. Chem., 287, 31311, 10.1074/jbc.M111.327056 · DOI
  28. Wennerberg, 2003, Rnd Proteins Function as RhoA Antagonists by Activating p190 RhoGAP, Curr. Biol., 13, 1106, 10.1016/S0960-9822(03)00418-4 · DOI
  29. Mori, 2009, Rho-kinase contributes to sustained RhoA activation through phosphorylation of p190A RhoGAP, J. Biol. Chem., 284, 5067, 10.1074/jbc.M806853200 · DOI
  30. Goh, L.L., and Manser, E. (2010). The RhoA GEF Syx Is a Target of Rnd3 and Regulated via a Raf1-Like Ubiquitin-Related Domain. PLoS ONE, 5. · DOI
  31. Zalcman, 2000, Interaction of the Grb7 adapter protein with Rnd1, a new member of the Rho family, FEBS Lett., 467, 91, 10.1016/S0014-5793(99)01530-6 · DOI
  32. Villalobo, 2013, Deletion of the calmodulin-binding domain of Grb7 impairs cell attachment to the extracellular matrix and migration, Biochem. Biophys. Res. Commun., 436, 271, 10.1016/j.bbrc.2013.05.092 · DOI
  33. Prokop, 2013, Using fly genetics to dissect the cytoskeletal machinery of neurons during axonal growth and maintenance, J. Cell Sci., 126, 2331
  34. Zanata, 2002, Antagonistic Effects of Rnd1 and RhoD GTPases Regulate Receptor Activity in Semaphorin 3A-Induced Cytoskeletal Collapse, J. Neurosci., 22, 471, 10.1523/JNEUROSCI.22-02-00471.2002 · DOI
  35. Oinuma, 2004, The Semaphorin 4D Receptor Plexin-B1 Is a GTPase Activating Protein for R-Ras, Science, 305, 862, 10.1126/science.1097545 · DOI
  36. Oinuma, 2003, Direct Interaction of Rnd1 with Plexin-B1 Regulates PDZ-RhoGEF-mediated Rho Activation by Plexin-B1 and Induces Cell Contraction in COS-7 Cells, J. Biol. Chem., 278, 25671, 10.1074/jbc.M303047200 · DOI
  37. Oinuma, 2004, Molecular Dissection of the Semaphorin 4D Receptor Plexin-B1-Stimulated R-Ras GTPase-Activating Protein Activity and Neurite Remodeling in Hippocampal Neurons, J. Neurosci., 24, 11473, 10.1523/JNEUROSCI.3257-04.2004 · DOI
  38. Yukawa, 2010, Sema4A induces cell morphological changes through B-type plexin-mediated signaling, Int. J. Mol. Med., 25, 225
  39. Harada, 2005, Direct interaction of Rnd1 with FRS2 beta regulates Rnd1-induced down-regulation of RhoA activity and is involved in fibroblast growth factor-induced neurite outgrowth in PC12 cells, J. Biol. Chem., 280, 18418, 10.1074/jbc.M411356200 · DOI
  40. Chardin, 2006, Function and regulation of Rnd proteins, Nat. Rev. Mol. Cell Biol., 7, 54, 10.1038/nrm1788 · DOI
  41. Costa, 2014, STI1 antagonizes cytoskeleton collapse mediated by small GTPase Rnd1 and regulates neurite growth, Exp. Cell Res., 324, 84, 10.1016/j.yexcr.2014.03.017 · DOI
  42. Li, 2009, Rnd1 regulates axon extension by enhancing the microtubule destabilizing activity of SCG10, J. Biol. Chem., 284, 16060, 10.1074/jbc.A808126200 · DOI
  43. Ogata, 2007, TGF-beta signaling-mediated morphogenesis: Modulation of cell adhesion via cadherin endocytosis, Genes Dev., 21, 1817, 10.1101/gad.1541807 · DOI
  44. Karaulanov, E., Böttcher, R.T., Stannek, P., Wu, W., Rau, M., Ogata, S., Cho, K.W.Y., and Niehrs, C. (2009). Unc5B Interacts with FLRT3 and Rnd1 to Modulate Cell Adhesion in Xenopus Embryos. PLoS ONE, 4. · DOI
  45. Komatsu, 2017, Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma, Ann. Surg. Oncol., 24, 850, 10.1245/s10434-016-5573-9 · DOI
  46. Qin, 2018, The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target, Cell Death Dis., 9, 486, 10.1038/s41419-018-0517-x · DOI
  47. Boyrie, 2018, RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma, Oncotarget, 9, 33788, 10.18632/oncotarget.26082 · DOI
  48. Jiang, 2003, Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers, Clin. Cancer Res., 9, 6432
  49. Nishigaki, 2005, Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays, Cancer Res., 65, 2115, 10.1158/0008-5472.CAN-04-3340 · DOI
  50. Xiang, 2016, RND1 is up-regulated in esophageal squamous cell carcinoma and promotes the growth and migration of cancer cells, Tumour Biol., 37, 773, 10.1007/s13277-015-3855-7 · DOI
  51. Aguirre, 2004, High-resolution characterization of the pancreatic adenocarcinoma genome, Proc. Natl. Acad. Sci. USA, 101, 9067, 10.1073/pnas.0402932101 · DOI
  52. Rutherford, 2005, Mapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinoma, Lab. Investig., 85, 1076, 10.1038/labinvest.3700314 · DOI
  53. Mouly, 2018, PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin, Cell Death Dis., 9, 931, 10.1038/s41419-018-0981-3 · DOI
  54. Nishigaki, 2005, Proteomic identification of differentially-expressed genes in human gastric carcinomas, Proteomics, 5, 3205, 10.1002/pmic.200401307 · DOI
  55. Soheili, 2017, Distinctive expression pattern of OCT4 variants in different types of breast cancer, Cancer Biomark., 18, 69, 10.3233/CBM-160675 · DOI
  56. Kar, 2018, Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression, Gene, 643, 35, 10.1016/j.gene.2017.11.077 · DOI
  57. Shen, 2014, Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation, Biochim. Biophys. Acta (BBA) Mol. Basis Dis., 1842, 2087, 10.1016/j.bbadis.2014.07.015 · DOI
  58. Li, W., Sun, M., Zang, C., Ma, P., He, J., Zhang, M., Huang, Z., Ding, Y., and Shu, Y. (2016). Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Cell Death Dis., 7. · DOI
  59. Qi, 2017, Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer, J. Hematol. Oncol., 10, 11, 10.1186/s13045-017-0420-4 · DOI
  60. Chen, 2018, Inferring Novel Tumor Suppressor Genes with a Protein-Protein Interaction Network and Network Diffusion Algorithms, Mol. Ther. Methods Clin. Dev., 10, 57, 10.1016/j.omtm.2018.06.007 · DOI
  61. Bianchini, 2007, cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib, Cancer Chemother. Pharmacol., 59, 349, 10.1007/s00280-006-0276-8 · DOI
  62. Turtoi, 2008, Early gene expression in human lymphocytes after gamma-irradiation—A genetic pattern with potential for biodosimetry, Int. J. Radiat. Biol., 84, 375, 10.1080/09553000802029886 · DOI

Cited by

Metadata

Authors
Mouly, L., Gilhodes, J., Lemarié, A., Cohen-Jonathan Moyal, E., Toulas, C., Favre, G., Sordet, O., & Monferran, S.
Affiliations
  • Cancer Research Center of Toulouse, INSERM UMR1037, 31037 Toulouse, France
  • Institut Claudius Regaud, IUCT-O, 31059 Toulouse, France
ORCID
Lemarié, Anthony
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2019-07-24
Volume
20
Issue
15
Pages
3612
ISSN
1422-0067
DOI
10.3390/ijms20153612
PMC
PMC6696182
Cited by
19
References
0
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
Région Midi-Pyrénées INSERM (R14075BB)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review